APhA Policy Manual

Non-FDA-Approved Drugs and Patient Safety

DRUG PRODUCT SELECTION EDUCATION, CURRICULUM AND COMPETENCE FOR PHARMACY PHARMACY PRACTICE

APhA calls for education and collaboration among health professional organizations, federal agencies, and other stakeholders to ensure that all manufacturer, distributor, and repackaged marketed prescription drugs used in patient care have been FDA-approved as safe and effective.
APhA supports initiatives aimed at closing legislative, regulatory, policy and distribution-system loopholes that facilitate market entry of new prescription drugs products without FDA approval.
APhA encourages health professionals to consider FDA approval status of prescription drug products when making decisions about prescribing, dispensing, substitution, purchasing, formulary development, and in the development of pharmacy/medical education programs and drug information compendia.